varespladib methyl

phospholipase A2 group X ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 15742431 A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. 2005 Mar 1
2 15801331 Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma. 2005 Feb 1